aewajin Derma Hydrocell 24k Gold Serum

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: aewajin Derma Hydrocell 24k Gold Serum
Generic name: GLYCERIN
Manufacturer: MISOCOS
Product type: HUMAN OTC DRUG
SPL set ID: a17b2c6e-9db8-bae4-e053-2a95a90adcf6
SPL ID: 1c79222b-edec-d38b-e063-6394a90a6e34
Version: 2
Effective date: 2024-07-05
Source export date: 2026-10-30
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/9abf0f8b126f8aad070e21ea702bfb5e39ce670b16ae57dd52e8877705d1bf5d/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:26:28

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		aewajin Derma Hydrocell 24k Gold Serum	openfda.brand_name
generic name		GLYCERIN	openfda.generic_name
manufacturer name		MISOCOS	openfda.manufacturer_name
ndc	package	73466-0005-1	openfda.package_ndc
ndc	product	73466-0005	openfda.product_ndc
ndc11	package	73466000501	derived:openfda.package_ndc
spl id		1c79222b-edec-d38b-e063-6394a90a6e34	id
spl set id		a17b2c6e-9db8-bae4-e053-2a95a90adcf6	set_id
unii		PDC6A3C0OX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

■ if following abnormal symptoms occurs after use , stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.